# Rituximab Combining With Low-Dose Mycophenolate Mofetil on Proliferative Lupus Nephritis in Children

> **NCT07675291** · NA · NOT_YET_RECRUITING · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 112 (estimated)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** rituximab
- **DRUG:** Mycophenolate Mofetil (MMF) Treatment
- **DRUG:** Cyclophosphamide
- **DRUG:** ACEI / ARB
- **DRUG:** Corticosteroid
- **DRUG:** Hydroxychloroquine (HCQ)

## Key facts

- **NCT ID:** NCT07675291
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2026-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07675291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07675291, "Rituximab Combining With Low-Dose Mycophenolate Mofetil on Proliferative Lupus Nephritis in Children". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07675291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*